English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduThe American College of Rheumatology said the Centers for Medicare and Medicaid Services’ Advancing Interoperability and Improving Prior Authorization Proposed Rule will bring greater transparency, reduce administrative burden, & make turnaround on prior authorization more predictable for payers.
Tag: prior authorization
AAOS to Congress: Protect Healthcare Services Before Years End
The American Association of Orthopaedic Surgeons (AAOS) is urging Congress to mitigate impending Medicare physician pay cuts and reform flawed prior authorization processes in year-end legislation.
House Passes Prior Authorization Relief Bill
The House voted overwhelmingly today to reform prior authorization under the Medicare Advantage program to help ensure America’s seniors get the care they need when they need it.
ACR Urges the FTC to Examine the Impact of Pharmacy Benefit Managers on Prescription Drug Costs
In comments submitted to the Federal Trade Commission (FTC), the American College of Rheumatology (ACR) urged the agency to address Pharmacy Benefit Manager (PBM) business practices that drive up costs and reduce access for the 54 million Americans living with rheumatic disease.
Increased access to care and reduced treatment delays lead priorities as radiation oncologists meet with members of Congress
Radiation oncologists will meet with congressional leaders and staff today to ask for their support of policies to bolster access and equity in cancer care. Today’s American Society for Radiation Oncology (ASTRO) Advocacy Day is the first to be held in-person since the start of the COVID-19 pandemic.
Prior authorization costs radiation oncology clinics more than $40 million each year, study estimates
The time required to secure prior authorization approvals for radiation therapy treatments equates to a financial impact of more than $40 million annually for academic medical centers, according to a new study. Findings will be presented today at the American Society for Radiation Oncology (ASTRO) Annual Meeting.
Nation’s Ophthalmologists Urge Congress to Protect Patients From Health Insurer Policy Disrupting Medically Necessary Care Across the Country
Today, the American Academy of Ophthalmology and the American Society of Cataract and Refractive Surgery sent a letter to members of Congress, asking for support in our ongoing effort to rein in excessive prior authorization requirements imposed by insurers.
Benefits manager policy disrupts patient-physician decision making for breast and prostate cancer radiation treatments
Radiation oncologists today expressed serious concerns about a new private insurance coverage policy that could undermine patient-centered care for two of the most common cancers in the United States. Leaders of the American Society for Radiation Oncology (ASTRO) urge eviCore, a radiation oncology benefits management company, to halt and make meaningful changes to a new policy for radiation therapy coverage. Under the new policy, EviCore mandates that most breast and prostate cancer treatments use a shorter, hypofractionated radiation therapy regimen even if it runs counter to a physician’s clinical recommendation.
Majority of House of Representatives Supports Prior Authorization Relief Bill
Introduced by Reps. Suzan DelBene (D-Wash.), Mike Kelly (R-Pa.), Roger Marshall, MD, (R-Kan.) and Ami Bera, MD, (D-Calif.), this legislation would help protect America’s seniors from unnecessary delays in care by streamlining and standardizing prior authorization under the Medicare Advantage program, providing much-needed oversight and transparency of health insurance for America’s seniors.
ACR Releases Position Statement on Prior Authorization
The American College of Rheumatology (ACR) has released an official position statement concerning prior authorization for the approval of prescription medications, highlighting the significant burdens it creates for patients and rheumatology professionals. This process can result in a significant delay of care or treatments, treatment abandonment and potential harm to patients.